Diagnostics guidance - static list
We regularly review our diagnostics guidance. If there is no new research or evidence available that would have a material effect on the guidance, it gets moved to the static list.
The following guidance has been transferred to the static list. If new evidence becomes available, the guidance can be transferred back to the active list for further appraisal.
Static list
Ref: DG1
Title: The EOS 2D/3D imaging system
Date issued: October 2011
Ref: DG3
Date issued: January 2012
Ref: DG5
Date issued: August 2012
Ref: DG6
Title: Depth of anaesthesia monitors - Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M
Date issued: November 2012
Ref: DG8
Date issued: August 2013
Ref: DG9
Title: EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer
Date issued: August 2013
Ref: DG11
Title: Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel
Date issued: October 2013
Ref: DG12
Title: Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath
Date issued: April 2014
DG12 Review decision
Ref: DG14
Date issued: September 2014
Ref: DG16
Title: Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment
Date issued: December 2014
Ref: DG19
Title: VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions
Date issued: November 2015
Ref: DG20
Title: SepsiTest assay for rapidly identifying bloodstream bacteria and fungi
Date issued: February 2016